Sign in to view content

COAST: A Phase 3 Study of Intravitreal Sozinibercept Combined With Aflibercept in Participants With Neovascular Age-Related Macular Degeneration

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2025

Related

Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial
Philip J. Ferrone, MD, FASRS
Annual Meeting Talks
2019
Early Vitrectomy vs Intravitreal Antibiotics Only for Postinjection Endophthalmitis: An IRIS (Intelligent Research in Sight) Registry Report
Andrew C Lin, MD
Annual Meeting Talks
2025
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more